Newsbenzinga
Disc Medicine Delivers Promise For Patients with Sunlight Sensitivity In Successful Pivotal Study
· Published
Article summary
Disc Medicine reports positive Phase 3 results for bitopertin in EPP, meeting all primary and secondary endpoints. NDA resubmission planned.
An excerpt from the original article.
Comments —
Loading comments…